The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer.
Options
BORIS DOI
Publisher DOI
PubMed ID
31100853
Description
Chronic proliferation is a major hallmark of tumor cells. Rapidly proliferating cancer cells are highly dependent on nutrients in order to duplicate their cell mass during each cell division. In particular, essential amino acids are indispensable for proliferating cancer cells. Their uptake across the cell membrane is tightly controlled by membrane transporters. Among those, the L-type amino acid transporter LAT1 (SLC7A5) has been repeatedly found overexpressed in a vast variety of cancers. In this review, we summarize the most recent advances in our understanding of the role of LAT1 in cancer and highlight preclinical studies and drug developments underlying the potential of LAT1 as therapeutic target.
Date of Publication
2019-05-16
Publication Type
Article
Subject(s)
500 - Science::570 - Life sciences; biology
600 - Technology::610 - Medicine & health
Keyword(s)
cancer inhibitor l-type amino acid transporter LAT1 preclinical studies targeted therapy
Language(s)
en
Additional Credits
Institut für Biochemie und Molekulare Medizin (IBMM)
Series
International journal of molecular sciences
Publisher
MDPI
ISSN
1661-6596
Access(Rights)
open.access